BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26542649)

  • 1. Clinical characteristics in adult patients with Salmonella bacteremia and analysis of ciprofloxacin-nonsusceptible isolates.
    Cheng MW; Lee CM; Wang NY; Wu AY; Lin CC; Weng LC; Liu CP; Shih SC
    J Microbiol Immunol Infect; 2015 Dec; 48(6):692-8. PubMed ID: 26542649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
    Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
    BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
    Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G
    J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
    Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
    Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China.
    Dong N; Li Y; Zhao J; Ma H; Wang J; Liang B; Du X; Wu F; Xia S; Yang X; Liu H; Yang C; Qiu S; Song H; Jia L; Li Y; Sun Y
    BMC Infect Dis; 2020 Jul; 20(1):511. PubMed ID: 32669095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.
    Eibach D; Al-Emran HM; Dekker DM; Krumkamp R; Adu-Sarkodie Y; Cruz Espinoza LM; Ehmen C; Boahen K; Heisig P; Im J; Jaeger A; von Kalckreuth V; Pak GD; Panzner U; Park SE; Reinhardt A; Sarpong N; Schütt-Gerowitt H; Wierzba TF; Marks F; May J
    Clin Infect Dis; 2016 Mar; 62 Suppl 1():S32-6. PubMed ID: 26933017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure.
    Dahiya S; Kapil A; Lodha R; Kumar R; Das BK; Sood S; Kabra SK
    Indian J Med Res; 2014 May; 139(5):746-53. PubMed ID: 25027085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin and nalidixic acid resistance of Salmonella spp. isolated from retail food in Poland.
    Mąka Ł; Maćkiw E; Stasiak M; Wołkowicz T; Kowalska J; Postupolski J; Popowska M
    Int J Food Microbiol; 2018 Jul; 276():1-4. PubMed ID: 29649749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.
    Dimitrov T; Dashti AA; Albaksami O; Udo EE; Jadaon MM; Albert MJ
    J Clin Microbiol; 2009 Jan; 47(1):208-11. PubMed ID: 18971360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.
    Hopkins KL; Arnold C; Threlfall EJ
    J Microbiol Methods; 2007 Jan; 68(1):163-71. PubMed ID: 16934351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
    García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
    PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H; Duan G; Zhu J; Zhang W; Xi Y; Fan Q
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
    Casas MR; Camargo CH; Soares FB; da Silveira WD; Fernandes SA
    Diagn Microbiol Infect Dis; 2016 May; 85(1):85-9. PubMed ID: 26971183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.